Elias A. Zerhouni - Jul 28, 2023 Form 4 Insider Report for DANAHER CORP /DE/ (DHR)

Role
Director
Signature
/s/ James F. O'Reilly, attorney-in-fact for Elias A. Zerhouni, M.D.
Stock symbol
DHR
Transactions as of
Jul 28, 2023
Transactions value $
$40,044
Form type
4
Date filed
8/1/2023, 05:02 PM
Previous filing
May 19, 2023
Next filing
Oct 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DHR Common Stock Options Exercise $177K +3.49K +12.91% $50.80* 30.5K Jul 28, 2023 Direct
transaction DHR Common Stock Tax liability -$177K -682 -2.23% $260.07 29.8K Jul 28, 2023 Direct
holding DHR Common Stock 7.5K Jul 28, 2023 By LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DHR Phantom shares Award $40.1K +154 +1.08% $260.07 14.5K Jul 28, 2023 Common Stock 154 $0.00 Direct F1, F2, F3
transaction DHR Director stock option (right to buy) Options Exercise $0 -3.49K -100% $0.00* 0 Jul 28, 2023 Common Stock 3.49K $50.80 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.
F2 Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.
F3 The reporting person is fully vested in all amounts deferred under the Plan.